Charles C J, Rademaker M T, Richards A M, Cooper G J, Coy D H, Nicholls M G
Christchurch Cardioendocrine Research Group, Christchurch School of Medicine, New Zealand.
J Cardiovasc Pharmacol. 2000 Oct;36(4):526-32. doi: 10.1097/00005344-200010000-00017.
Biologic actions attributed to adrenomedullin include reduction of arterial pressure and suppression of aldosterone secretion. To assess possible in vivo antiangiotensin II actions of adrenomedullin, we examined hemodynamic and adrenal responses to stepped angiotensin II infusions with or without co-infusions of adrenomedullin (33 ng/kg/min) in conscious sheep under controlled conditions of a low sodium intake. Plasma adrenomedullin levels rose during peptide infusions (p < 0.001) to plateau at approximately 15-18 pM. The dose-dependent pressor response (15-20 mm Hg) of angiotensin II was both delayed and markedly attenuated (p = 0.017) by adrenomedullin, which also stimulated heart rate (p < 0.001) and cardiac output (p < 0.001). Adrenomedullin prevented the angiotensin II-induced increase in peripheral resistance (p < 0.001). Plasma aldosterone responses to angiotensin II were variable and were not significantly altered by concomitant adrenomedullin infusion. In conclusion, low-dose infusion of adrenomedullin administered to conscious sheep on a low-salt diet clearly antagonized the vasopressor actions of administered angiotensin II while stimulating cardiac output and heart rate. The data suggest a possible role for adrenomedullin in cardiovascular homeostasis in part through antagonism of the vasopressor action of angiotensin II.
肾上腺髓质素的生物学作用包括降低动脉血压和抑制醛固酮分泌。为了评估肾上腺髓质素在体内可能的抗血管紧张素II作用,我们在低钠摄入的可控条件下,研究了清醒绵羊在输注血管紧张素II时,无论是否同时输注肾上腺髓质素(33 ng/kg/分钟)时的血流动力学和肾上腺反应。在输注肽期间,血浆肾上腺髓质素水平升高(p < 0.001),并在约15 - 18 pM达到平台期。肾上腺髓质素使血管紧张素II的剂量依赖性升压反应(15 - 20 mmHg)延迟且明显减弱(p = 0.017),同时还刺激心率(p < 0.001)和心输出量(p < 0.001)。肾上腺髓质素可防止血管紧张素II引起的外周阻力增加(p < 0.001)。血管紧张素II引起的血浆醛固酮反应变化不定,同时输注肾上腺髓质素并未使其发生显著改变。总之,给低钠饮食的清醒绵羊输注低剂量肾上腺髓质素,明显拮抗了所输注血管紧张素II的升压作用,同时刺激了心输出量和心率。数据表明,肾上腺髓质素可能在心血管稳态中发挥作用,部分是通过拮抗血管紧张素II的升压作用实现的。